Well, good people. Here we are waiting on the Nove
Post# of 7798
(Total Views: 1074)
Posted On: 09/25/2020 1:53:23 PM
Well, good people. Here we are waiting on the November 15th financials. What will the numbers be? Substantial increase is in the works. How substantial will be answered in the financial statement. Below is how revenue is recorded as stated online. It’s important to understand the difference between purchase orders, deposits and when products exchange hands.
Revenue is recorded at the time of the sale when the products or services exchange hands. Revenue is not recorded when payment is received, but rather beforehand. This is so because companies often sell items on credit that is to be paid later. On a company's balance sheet, this line item is accounts receivable; the amount that the company is expected to collect as revenue.
When payment is finally made, revenue is not increased as it was already recorded. On the balance sheet, accounts receivables are decreased and cash increases.
Yes, to receive orders, new partners, new licensing agreements is great but the bottom line is “Delivery of the Products”
We have great partners on board and more to come, yes a lot more to come.
What’s being overlooked are licensing agreements, there are fees, royalties and don’t forget branding by the new agreements are taking place. We will see the product out there branded under other names and some may think it is our competition but in fact it’s us!
There may be another update prior to the press release stating the North America launch. The update will reveal more great actions going on in the company.
Please don’t expect all the golden eggs in one or two financial reports, this is a growing company launching worldwide over the next few quarters so let’s keep the pathway clear and clean.
I have great respect for all the positive posters, their comments and last but not least their estimates.
Guys you are all way off with sales estimates! In the coming quarters including next year you must all take into consideration “Worldwide Launch” We have to grasp the concept that our products will be in markets all over the world and in most if not all retail that supply pain relief.
Have a great day and stay safe.
Revenue is recorded at the time of the sale when the products or services exchange hands. Revenue is not recorded when payment is received, but rather beforehand. This is so because companies often sell items on credit that is to be paid later. On a company's balance sheet, this line item is accounts receivable; the amount that the company is expected to collect as revenue.
When payment is finally made, revenue is not increased as it was already recorded. On the balance sheet, accounts receivables are decreased and cash increases.
Yes, to receive orders, new partners, new licensing agreements is great but the bottom line is “Delivery of the Products”
We have great partners on board and more to come, yes a lot more to come.
What’s being overlooked are licensing agreements, there are fees, royalties and don’t forget branding by the new agreements are taking place. We will see the product out there branded under other names and some may think it is our competition but in fact it’s us!
There may be another update prior to the press release stating the North America launch. The update will reveal more great actions going on in the company.
Please don’t expect all the golden eggs in one or two financial reports, this is a growing company launching worldwide over the next few quarters so let’s keep the pathway clear and clean.
I have great respect for all the positive posters, their comments and last but not least their estimates.
Guys you are all way off with sales estimates! In the coming quarters including next year you must all take into consideration “Worldwide Launch” We have to grasp the concept that our products will be in markets all over the world and in most if not all retail that supply pain relief.
Have a great day and stay safe.
(9)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼